About 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 158759650) has the molecular formula C194H183B4Br4IN16O8
and a molecular weight of 3356.47 g/mol. Its IUPAC name is 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
Frequently Asked Questions
What is the IUPAC name of 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The IUPAC name of 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 158759650) is 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
What is the SMILES notation for 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The canonical SMILES for 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is Brc1ccc(-c2nc3ccccc3n2-c2ccccc2)nc1.Brc1ccc(I)nc1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)nc4)cn3)cc2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cn3)cc2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(Br)cn3)cc2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc(B(O)O)cc2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc(Br)cc2)cc1.Cc1ccc(N(c2ccccc2)c2ccc(C)cc2)cc1.
What is the InChIKey of 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The InChIKey is IOMRLCDPIAGLRG-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H33N5.C31H33BN2O2.C25H21BrN2.C20H20BNO2.C20H18BrN.C20H19N.C18H12BrN3.C12H24B2O4.C5H3BrIN/c1-30-12-20-36(21-13-30)47(37-22-14-31(2)15-23-37)38-24-16-32(17-25-38)39-26-18-33(28-44-39)34-19-27-41(45-29-34)43-46-40-10-6-7-11-42(40)48(43)35-8-4-3-5-9-35;1-22-7-14-26(15-8-22)34(27-16-9-23(2)10-17-27)28-18-11-24(12-19-28)29-20-13-25(21-33-29)32-35-30(3,4)31(5,6)36-32;1-18-3-10-22(11-4-18)28(23-12-5-19(2)6-13-23)24-14-7-20(8-15-24)25-16-9-21(26)17-27-25;1-15-3-9-18(10-4-15)22(19-11-5-16(2)6-12-19)20-13-7-17(8-14-20)21(23)24;1-15-3-9-18(10-4-15)22(19-11-5-16(2)6-12-19)20-13-7-17(21)8-14-20;1-16-8-12-19(13-9-16)21(18-6-4-3-5-7-18)20-14-10-17(2)11-15-20;19-13-10-11-16(20-12-13)18-21-15-8-4-5-9-17(15)22(18)14-6-2-1-3-7-14;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;6-4-1-2-5(7)8-3-4/h3-29H,1-2H3;7-21H,1-6H3;3-17H,1-2H3;3-14,23-24H,1-2H3;3-14H,1-2H3;3-15H,1-2H3;1-12H;1-8H3;1-3H.
What are the key properties of 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 3356.47 g/mol, XLogP of 50.95, 29 rotatable bonds, 2 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-2-iodopyridine;N-(4-bromophenyl)-4-methyl-N-(4-methylphenyl)aniline;2-(5-bromo-2-pyridinyl)-1-phenylbenzimidazole;N-[4-(5-bromo-2-pyridinyl)phenyl]-4-methyl-N-(4-methylphenyl)aniline;[4-(4-methyl-N-(4-methylphenyl)anilino)phenyl]boronic acid;4-methyl-N-(4-methylphenyl)-N-phenylaniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-2-pyridinyl]phenyl]aniline;4-methyl-N-(4-methylphenyl)-N-[4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]phenyl]aniline;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 158759650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).